RITUXIMAB IN RESISTANT MYASTHENIA GRAVIS

被引：0
|
作者：
Anderson, D.
Siddiqi, Z.
机构：
来源：
MUSCLE & NERVE | 2015年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S137 / S137
页数：1
相关论文
共 50 条
  • [31] Rituximab therapy for morvan syndrome associated with myasthenia gravis
    Weiss, Michael
    MUSCLE & NERVE, 2012, 46 (01) : 139 - 140
  • [32] Beneficial effect of tocilizumab in myasthenia gravis refractory to rituximab
    Jonsson, Dagur Ingi
    Pirskanen, Ritva
    Piehl, Fredrik
    NEUROMUSCULAR DISORDERS, 2017, 27 (06) : 565 - 568
  • [33] Generalised and refractory Myasthenia gravis with a positive response to rituximab
    Machado, S.
    Costa, S.
    Alves, J.
    Valverde, A.
    JOURNAL OF NEUROLOGY, 2011, 258 : 248 - 248
  • [34] Successful treatment of refractory generalized myasthenia gravis with rituximab
    Lebrun, C.
    Bourg, V.
    Tieulie, N.
    Thomas, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (02) : 246 - 250
  • [35] Use and monitoring of low dose rituximab in myasthenia gravis
    Blum, Stefan
    Gillis, David
    Brown, Helen
    Boyle, Richard
    Henderson, Robert
    Heyworth-Smith, David
    Hogan, Patrick
    Kubler, Paul
    Lander, Cecilie
    Limberg, Nicole
    Pillans, Peter
    Prain, Kerri
    Staples, Christopher
    Walsh, Michael
    McCombe, Pamela
    Wong, Richard
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2011, 82 (06): : 659 - 663
  • [36] Rituximab in myasthenia gravis: a retrospective study of 7 cases
    Duarte, S.
    Oliveira, V.
    Samoes, R.
    Sousa, A. P.
    Martins Silva, A.
    Santos, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 503 - 503
  • [37] Rituximab in the treatment of pembrolizumab-induced myasthenia gravis
    Crusz, S. M.
    Radunovic, A.
    Shepherd, S.
    Shah, S.
    Newey, V.
    Phillips, M.
    Lim, L.
    Powles, T.
    Szlosarek, P. W.
    Shamash, J.
    Rashid, S.
    EUROPEAN JOURNAL OF CANCER, 2018, 102 : 49 - 51
  • [38] Comparison Between Rituximab Treatment for New-Onset Generalized Myasthenia Gravis and Refractory Generalized Myasthenia Gravis
    Brauner, Susanna
    Eriksson-Dufva, Ann
    Hietala, Max Albert
    Frisell, Thomas
    Press, Rayomand
    Piehl, Fredrik
    JAMA NEUROLOGY, 2020, 77 (08) : 974 - 981
  • [39] Rituximab as Adjunct Maintenance Therapy for Refractory Juvenile Myasthenia Gravis
    Zingariello, Carla D.
    Elder, Melissa E.
    Kang, Peter B.
    PEDIATRIC NEUROLOGY, 2020, 111 : 40 - 43
  • [40] AN INDIRECT COMPARISON OF EFGARTIGIMOD VERSUS RITUXIMAB FOR GENERALIZED MYASTHENIA GRAVIS
    Celico, L.
    Spaepen, E.
    De Francesco, M.
    Iannazzo, S.
    VALUE IN HEALTH, 2022, 25 (12) : S42 - S42
12345